SCHEMBL3633282

SCHEMBL3633282

COC(=O)C1C[C@@H](O)CN1Cc1ccc(Cl)c(Cl)c1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
CYP3A4 P08684 7/20 0.46
KDM4E B2RXH2 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
OPRK1 P41145 3/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
TSHR P16473 1/20 0.45
GRM5 P41594 1/20 0.45
MCHR1 Q99705 1/20 0.43
MAOA P21397 1/20 0.42
MAOB P27338 1/20 0.42
SLC6A4 P31645 1/20 0.41
ATM Q13315 1/20 0.41
KMT2A Q03164 1/20 0.41
MC3R P41968 1/20 0.41
MC1R Q01726 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2817870 1.00 ALDH1A1 (0.47) ALDH1A1CYP3A4KDM4ESMN1; SMN2OPRK1
SCHEMBL3633284 1.00 ALDH1A1 (0.47) ALDH1A1CYP3A4KDM4ESMN1; SMN2OPRK1
SCHEMBL2820776 0.84 MAOA (0.46) CYP3A4KDM4EOPRK1MAOAMAOB
SCHEMBL19875740 0.83 CYP3A4 (0.59) ALDH1A1CYP3A4KDM4EMAOAMAOB
SCHEMBL19875739 0.83 CYP3A4 (0.59) ALDH1A1CYP3A4KDM4EMAOAMAOB
SCHEMBL24938939 0.83 CYP3A4 (0.50) ALDH1A1CYP3A4KDM4EMAOAMAOB
SCHEMBL4249938 0.83 CYP3A4 (0.50) ALDH1A1CYP3A4KDM4EMAOAMAOB
SCHEMBL15325590 0.83 CYP3A4 (0.50) ALDH1A1CYP3A4KDM4EMAOAMAOB
SCHEMBL5368566 0.83 CYP3A4 (0.50) ALDH1A1CYP3A4KDM4EMAOAMAOB
SCHEMBL19408855 0.83 CYP3A4 (0.50) ALDH1A1CYP3A4KDM4EMAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2155672-A1 PROLINAMIDE DERIVATIVES AS NK3 ANTAGONISTS F. Hoffmann-Roche AG (CH) 2010-02-24 EP disclosed
WO-2008148689-A1 PROLINAMIDE DERIVATIVES AS NK3 ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2008-12-11 WO disclosed